Forward is all about proactive versus reactive healthcare and at the center of it is founder and CEO Adrian Aoun. He joins Alyssa Julya Smith at Forward's Los Angeles location to talk about some of the benefits of Forward and how technology is being used to help with preventative healthcare. He explains that Tesla's and iPhone's can predict when they're likely to break down and intervene to fix things before it happens and that should be the same with healthcare. Forward created personalized health plans through an in-depth understanding of a person's genetics, blood test results, biomarkers and daily lifestyle. Aoun also explains that Forward doesn't use insurance, but is based on a monthly membership cost that allows Forward to do full diagnostic tests without hidden fees or bills from blood work or other lab testing, explaining that it's all done in the office.

Share:
More In Business
Virgin Orbit Partners With Japan To Bring Air Launch To Asia
Virgin Orbit is introducing air-launch services to the Eastern Hemisphere for the first time in history. Sir Richard Branson's space launch company has signed an agreement with ANA Holdings, the owners of Japan's largest airline, to procure 20 flights of its LauncherOne rocket from an airport in Japan, a big boost for the aerospace industry in Asia. Dan Hart, CEO of Virgin Orbit, joined Cheddar to discuss the new partnership, the future of air launch, and how small satellites can help monitor climate change impacts.
Morning Consult Releases U.S. Economic Outlook for November
Almost 2 years into the pandemic, supply chain woes continue to wreak havoc on our everyday lives. From groceries to chip shortages, both consumers and retailers are feeling the strain with prices only climbing as a result. Data intelligence company Morning Consult is out with its U.S. Economic Outlook for November revealing just how much of a threat these hold-ups could pose to the greater economic recovery. John Leer, Chief Economist at Morning Consult joined Cheddar's Opening Bell.
Economic Impact of Biden's $1.2 trillion Infrastructure Bill
After many years and at least two presidents hoping to overhaul America's infrastructure, congress finally came to an agreement. The House passed the bipartisan infrastructure bill late Friday, receiving thirteen republican votes but failing to earn votes from the six progressive squad members. Joseph Zeballos-Roig, Economics Reporter at Insider joined Cheddar's Opening Bell to discuss the economic impact of the bill.
Regeneron Joins Battle Against COVID-19, Releases Stats on New COVID Treatment
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Peloton Stock Continues Steep Drop as It Loses More Than $10B in Value
Doug Astrop, managing partner at Exponential Investment Partners, joined Cheddar to discuss Peloton's precipitous price drop, and whether the company can recover as the at-home workout trend tapers off. "They've lowered the prices on their equipment to try to attract a bigger audience because ultimately they're sort of headed to this Apple ecosystem model where they can monetize a loyal customer base," he said. Astrop noted that he believes there is a reality where the in-person gym experience and Peloton's at-home programs can co-exist.
Markets Look to Continue Record Run
Bill Stone, Chief Investment Officer at Glenview Trust Company, joined Wake Up With Cheddar to break down markets headlines ahead of the start of the trading week.
Load More